Trial Profile
Prospective, randomized, placebo-controlled study of atorvastatin and omega-3 fatty acid ethyl esters in obese, insulin-resistant men
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Hyperlipoproteinaemia; Hypertriglyceridaemia
- Focus Pharmacodynamics
- Sponsors Pfizer
- 06 Nov 2015 New trial record